mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.006 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.008 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |